↓ Skip to main content

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung…

Overview of attention for article published in BMC Cancer, December 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

googleplus
1 Google+ user
reddit
1 Redditor

Readers on

mendeley
12 Mendeley
Title
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
Published in
BMC Cancer, December 2018
DOI 10.1186/s12885-018-5146-3
Authors

Yasuhiro Tsutani, Yoshihiro Miyata, Takeshi Masuda, Kazunori Fujitaka, Mihoko Doi, Yoshikazu Awaya, Shoichi Kuyama, Soichi Kitaguchi, Kazuhiro Ueda, Noboru Hattori, Morihito Okada

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 25%
Librarian 2 17%
Student > Doctoral Student 2 17%
Student > Bachelor 2 17%
Student > Master 1 8%
Other 2 17%
Readers by discipline Count As %
Medicine and Dentistry 5 42%
Nursing and Health Professions 3 25%
Biochemistry, Genetics and Molecular Biology 2 17%
Social Sciences 1 8%
Unspecified 1 8%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 December 2018.
All research outputs
#7,883,104
of 13,079,903 outputs
Outputs from BMC Cancer
#2,109
of 4,881 outputs
Outputs of similar age
#180,194
of 321,293 outputs
Outputs of similar age from BMC Cancer
#248
of 633 outputs
Altmetric has tracked 13,079,903 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,881 research outputs from this source. They receive a mean Attention Score of 4.0. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 321,293 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 633 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.